Alzheimer Disease and Environmental Exposure to Neurotoxic Factors: A Controversy

References (75)

1. 1 Global prevalence of dementia: a Delphi consensus study [DOI]
2. 2 Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis [DOI]
3. 3 Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial [DOI]
4. 4 Oxidative stress and mitochondrial dysfunction in Alzheimer's disease [DOI]
5. 5 The three modern faces of mercury. [DOI]
6. 6 Human Health Risk Assessment for Aluminium, Aluminium Oxide, and Aluminium Hydroxide [DOI]
7. 7 Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. [DOI]
8. 8 Geographical relation between Alzheimer's disease and aluminum in drinking water.
9. 9 Parkinson's Disease and Residential Exposure to Maneb and Paraquat From Agricultural Applications in the Central Valley of California [DOI]
10. 10 Aluminum and Alzheimer's Disease: After a Century of Controversy, Is there a Plausible Link? [DOI]
11. 11 The neurotoxicity of environmental aluminum is still an issue [DOI]
12. 12 Environmental risk factors for Parkinson’s disease and parkinsonism: the Geoparkinson study [DOI]
13. 13 Aluminum in hippocampal neurons from humans with Alzheimer's disease [DOI]
14. 14 Occupation and risk of parkinsonism: a multicenter case-control study. [DOI]
15. 15 ORGANOCHLORINE INSECTICIDES IN SUBSTANTIA NIGRA IN PARKINSON'S DISEASE [DOI]
16. 16 Neuropsychological and Renal Effects of Dental Amalgam in Children [DOI]
17. 17 Is Pesticide Use Related to Parkinson Disease? Some Clues to Heterogeneity in Study Results [DOI]
18. 18 Mercury Induces Cell Cytotoxicity and Oxidative Stress and Increases β‐Amyloid Secretion and Tau Phosphorylation in SHSY5Y Neuroblastoma Cells [DOI]
19. 19 Involvement of Environmental Mercury and Lead in the Etiology of Neurodegenerative Diseases [DOI]
20. 20 The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis [DOI]
21. 21 Occupational risk factors in Alzheimers disease: a review assessing the quality of published epidemiological studies [DOI]
22. 22 The Earliest Stage of Cognitive Impairment in Transition From Normal Aging to Alzheimer Disease Is Marked by Prominent RNA Oxidation in Vulnerable Neurons [DOI]
23. 23 Molecular toxicity of aluminium in relation to neurodegeneration.
24. 24 Chronic Aluminum Intake Causes Alzheimer's Disease: Applying Sir Austin Bradford Hill's Causality Criteria [DOI]
25. 25 EXPERIMENTAL PRODUCTION OF NEUROFIBRILLARY DEGENERATION [DOI]
26. 26 ALUMINIUM, NEUROFIBRILLARY DEGENERATION AND ALZHEIMER'S DISEASE [DOI]
27. 27 A case‐control study of Alzheimer's disease in Australia [DOI]
28. 28 EXPERIMENTAL PRODUCTION OF NEUROFIBRILLARY DEGENERATION [DOI]
29. 29 Incorporating pharmacokinetic differences between children and adults in assessing children's risks to environmental toxicants [DOI]
30. 30 Effects on the nervous system among welders exposed to aluminium and manganese. [DOI]
31. 31 Alzheimer disease: mercury as pathogenetic factor and apolipoprotein E as a moderator.
32. 32 Health effects of dental amalgam exposure: a retrospective cohort study [DOI]
33. 33 Increased blood mercury levels in patients with Alzheimer's disease [DOI]
34. 34 Mechanisms by which metals promote events connected to neurodegenerative diseases [DOI]
35. 35 Occupational aluminum exposure: Evidence in support of its neurobehavioral impact [DOI]
36. 36 Decrements in cognitive performance in metal inert gas welders exposed to aluminium. [DOI]
37. 37 Brain lesions comprised of aluminum-rich cells that lack microtubules may be associated with the cognitive deficit of Alzheimer's disease [DOI]
38. 38 Intoxication par le mercure [DOI]
39. 39 ALZHEIMER'S DISEASE, DENTAL AMALGAM AND MERCURY [DOI]
40. 40 In vitro evidence for the hole of glutamate in the CNS toxicity of mercury [DOI]
41. 41 Increased absorption of aluminium from a normal dietary intake in dementia [DOI]
42. 42 Apolipoprotein E genotyping as a potential biomarker for mercury neurotoxicity [DOI]
43. 43 Prevalence of dementia in the older Japanese‐Brazilian population [DOI]
44. 44 Mental abilities of workers exposed to aluminium.
45. 45 Epidemiology of dementia [DOI]
46. 46 Mortality with Alzheimer's disease and dementia in France, 2006 [DOI]
47. 47 The epidemiology of Alzheimer’s disease and vascular dementia in Japanese and African-American populations: the search for etiological clues [DOI]
48. 48 The Faroes Statement: Human Health Effects of Developmental Exposure to Chemicals in Our Environment [DOI]
49. 49 Exposure to aluminium and the subsequent development of a disorder with features of Alzheimer's disease [DOI]
50. 50 The Delayed Appearance of a Mercurial Warning [DOI]
51. 51 A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. [DOI]
52. 52 Developmental neurotoxicity of industrial chemicals [DOI]
53. 53 Relation between Aluminum Concentrations in Drinking Water and Alzheimer's Disease: An 8-year Follow-up Study [DOI]
54. 54 Pesticide Exposure and Self-reported Parkinson's Disease in the Agricultural Health Study [DOI]
55. 55 Aluminum and Silica in Drinking Water and the Risk of Alzheimer's Disease or Cognitive Decline: Findings From 15-Year Follow-up of the PAQUID Cohort [DOI]
56. 56 Neurodegenerative Diseases and Exposure to Pesticides in the Elderly [DOI]
57. 57 Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada [DOI]
58. 58 Neurobehavioral effects of dental amalgam in children: a randomized clinical trial. [DOI]
59. 59 Mercury in human brain, blood, muscle and toenails in relation to exposure: an autopsy study [DOI]
60. 60 EPIDEMIOLOGY OF DEMENTIA [DOI]
61. 61 Does Inorganic Mercury Play a Role in Alzheimer's Disease? A Systematic Review and an Integrated Molecular Mechanism [DOI]
62. 62 Aluminum and its potential contribution to Alzheimer's disease (AD) [DOI]
63. 63 Oxidative Stress and its Implications for Future Treatments and Management of Alzheimer Disease [DOI]
64. 64 Prevalence of Dementia and Its Subtypes in the Japanese American Population of King County, Washington State: The Kame Project [DOI]
65. 65 Retrograde degeneration of neurite membrane structural integrity of nerve growth cones following in vitro exposure to mercury [DOI]
66. 66 Neurobehavioral effects of long-term exposure to pesticides: results from the 4-year follow-up of the PHYTONER Study [DOI]
67. 67 A review of genome mutation and Alzheimer's disease [DOI]
68. 68 An ignored risk factor in toxicology: The total imprecision of exposure assessment [DOI]
69. 69 Comparative epidemiology of multiple sclerosis and dental caries. [DOI]
70. 70 Neurobehavioral Effects of Dental Amalgam in Children: A Randomized Clinical Trial [DOI]
71. 71 Neuropsychological and Renal Effects of Dental Amalgam in Children: A Randomized Clinical Trial [DOI]
72. 72 [Human neurotoxicity of ethylene-bis-dithiocarbamates (EBDC)]
73. 73 [Occupational cancers: notification, compensation and prevention].
74. 74 Developmental neurotoxicity of industrial chemicals [DOI]
75. 75 Editorial: Children’s Health and the Environment: A Transatlantic Dialogue [DOI]

Cited by 3

Showing 1 of 3 known citations — external sources report more than can currently be individually listed.

Related research

• Ameliorative Histological Effects of Aqueous Neem Leaf Extract (Azadirachta indica) on Lead Induced Neurotoxicity of Lateral Geniculate Body of Adult Wistar Rats — shares topic coverage
• Mechanisms of Prooxidants in NeuroInflammatory Processes and Clinical Manifestations — shares topic coverage
• Overview of Adverse Events Associated with Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy — shares topic coverage
• Iatrogenic Baclofen Neurotoxicity in End Stage Renal Disease: A Case Report and Review of Literature — shares topic coverage
• The Roles of Hydrogen Peroxide Exposure in the Toxic Aggregation of Alpha-synuclein and Translocation of DNA Methyltransferase-1 in Human Neuroblastoma Cell Model of Parkinson's Disease — shares topic coverage